top of page
About Us
Team
Advisors
Science
Pipeline
Investors
News
More
Use tab to navigate through the menu items.
Company News
Rezubio Announces FDA and NMPA IND Clearances and First Cohort Dosing of RZ-520, a Novel Inhaled Therapy for Chronic Respiratory Diseases
Read More
Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platform and Company Pipeline, with Lead Program in Obesity and Diabetes
Read More
bottom of page
